Central SOEs' Efforts

  • >

    Fighting COVID-19: Central SOEs' Efforts

    Since the COVID-19 outbreak, Chinese central SOEs have been making all-out efforts to support the battle against the virus not only in medical material production and development but also by transporting supplies to the front-lines, and in other ways as well.

  • >

    Central Pharmaceutical SOEs Speed up R&D, Production to Guarantee Medical Care

    China National Pharmaceutical Group Co., Ltd. (Sinopharm) has used its technology and capacity advantages to develop and produce nucleic acid diagnostic reagents soon after the outbreak of novel coronavirus.

UPDATES

Timeline of China Releasing Information on COVID-19 and Advancing International Cooperation
Temporary Quarantine Center under Construction in Quanzhou, E China
Bangladesh Signs Pact to Make 5m Sinopharm Vaccine Doses
East China's Yangzhou Builds Two Advanced Air-Inflated Testing Labs
Standing Together, Caring Global
COVID Vaccines Get Export Push
Inactivated Vaccines Agile in Tackling New Variants, Experts Say
Refrigeratory's Main Body of COVID-19 Inactivated Vaccine Expansion Project in Wuhan Completed

PHOTOS